Melanotan II
A synthetic analog of alpha-melanocyte-stimulating hormone; not FDA-approved.
What it is
Melanotan II is a synthetic analog of the hormone that drives melanin production. It emerged from legitimate university research into UV-free tanning, but development as a drug stopped — and what circulates today is an unregulated injectable sold through gray-market channels.
Health agencies in several countries have issued explicit warnings against it, citing reported adverse events and the risks of unregulated injectables. Its cousin afamelanotide is an approved drug for a rare photosensitivity disorder — a useful contrast between a molecule that finished the regulatory journey and one that didn't.
What researchers have actually studied it for
Skin pigmentation and, in early research, erectile function; development stopped short of approval and health agencies have warned against its use.
How it works
A potent, non-selective melanocortin agonist: it drives melanocytes to produce melanin (the tan), while its off-target receptor activity produces the appetite suppression and sexual effects that made its pharmacology famous — non-selectivity is precisely why it was never developable as a tanning drug.
The molecule itself
A cyclic heptapeptide alpha-MSH analog — bremelanotide's direct chemical ancestor (bremelanotide is essentially melanotan II with a single modification) — hitting MC1R (tanning), MC4R (sexual effects) and MC3R broadly. Its non-selectivity is the whole story: one small ring, four receptor programs.
Where it came from
The same University of Arizona program that led to bremelanotide created melanotan II in the early 1990s, aiming at sunless tanning for skin-cancer prevention. Licensing efforts fizzled; the synthesis escaped into gray-market labs in the 2000s, and 'tan-jab' warnings from health agencies have followed it since.
The timeline
1980s–90s
Arizona melanotropin program designs it for UV-free tanning.
1990s
Early human studies confirm pigmentation — and the side-effect portfolio.
2000s
Licensing fails; synthesis escapes to gray-market labs; 'tan jab' era begins.
2010s+
Health agencies (UK, EU, Australia, US) issue warnings; mole-change case reports accumulate.
What the research record actually contains
- Small early human studies confirming pigmentation and the famous side-effect profile.
- No completed development program; no controlled safety characterization.
- A parallel legitimate molecule — afamelanotide (Scenesse) — approved for erythropoietic protoporphyria, showing what the finished path looks like.
What could change this assessment
No development path exists or will; its future is enforcement and dermatology case literature. The one watchable item is mole-surveillance research, which keeps sharpening the warnings.
What's known about risks
Reported concerns include nausea, flushing, blood-pressure effects, appetite suppression, spontaneous erections — and the dermatological one clinicians emphasize: darkening and changing moles, with case reports of atypical lesions prompting biopsies. Unregulated vials and home injection multiply every risk.
Where it stands legally
Unapproved in the US, UK, EU and Australia; multiple regulators have acted against sellers. Persistently available anyway — as an unregulated injectable with none of the protections its buyers assume.
Worth asking a licensed provider
- 1.Given my skin type and mole history, what surveillance would even be needed if I'd used this?
- 2.What legitimate photoprotection strategies fit my situation?
- 3.Am I confusing this with the approved drug afamelanotide, and does that pathway apply to me?
Common claims, corrected
“A tan from MT-2 protects like a natural tan.”
Reality: Melanin offers modest protection regardless of origin, but the compound's melanocyte stimulation alongside UV exposure — and its mole effects — make 'safer tanning' a claim dermatology explicitly rejects.
“It's basically approved — its cousin is a drug.”
Reality: Its cousin succeeded by removing what makes MT-2 problematic. The comparison demonstrates the difference between finished pharmaceutical development and its raw material.
Melanotan II FAQ
Is Melanotan II safe?
Multiple national health agencies have warned against it. Reported concerns include nausea, blood-pressure effects, and changing moles — the last worth taking seriously with any melanocyte-stimulating compound. Unregulated sourcing adds its own risks.
Is Melanotan II legal?
It is not an approved drug in the US, UK, EU or Australia, and several regulators have acted against sellers. It persists as an unregulated online product.
Does Melanotan II work for tanning?
It does stimulate melanin production — the mechanism is real, which is exactly why regulators worry about unsupervised use. 'It works' and 'it is safe' are different claims.
What should someone who has used MT-2 actually do?
Skin surveillance is the practical answer: melanocyte-stimulating compounds and changing moles are a combination dermatologists want to see. A skin check is cheap; melanoma vigilance is the one non-negotiable.
Why do agencies single out melanotan?
It combines real pharmacological potency, unregulated injectable supply, cosmetic motivation (wide casual use), and a plausible cancer-adjacent mechanism — the exact profile warning systems exist for.